Document is current
Any future updates will be listed below
-
Authors
Guzman-Holst, Adriana https://orcid.org/0000-0002-6753-2541
Gupta, Digant https://orcid.org/0000-0002-1963-8886
Kaur, Amandeep https://orcid.org/0009-0009-0412-0118
Verma, Vikas https://orcid.org/0009-0004-6495-1929
Berzanskis, Arnas https://orcid.org/0009-0005-5456-405X
Penders, Yolanda https://orcid.org/0000-0002-7606-7987
Van Oorschot, Désirée A. M. https://orcid.org/0000-0002-0382-0333
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 17 August 2025
First Online: 5 September 2025
Declarations
:
: Adriana Guzman-Holst, Arnas Berzanskis, Yolanda Penders, and Désirée A. M. Van Oorschot are employees of and hold financial equities in GSK. Digant Gupta, Amandeep Kaur, and Vikas Verma are employees of Bridge Medical, which was contracted by GSK for this study.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
